Atezolizumab,Cabozantinib
Roche
[]
may pd-l1 inhibition be better than pd-l1? may delayed io retreatment improve outcomes? excellent discussion by #asco23 
Oncólogo médico en @parctauli y Hospital de Barcelona. Vocal de la Junta Directiva de @sogug1. Wine lover. Life-enjoying!